Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details Narrative)

v3.22.1
Related Party Transactions (Details Narrative)
3 Months Ended
Mar. 31, 2022
Tactic Pharma LLC  
Beneficial Ownership 34.00%